During early drug development and preclinical development, researchers use in vitro cultured lymphocytes to induce cytokine ...

T cells are a natural part of the immune system designed to fight infections and cancer, but in conditions like blood cancer, they may not be able to eliminate malignant cells, according to Dr.

The study reviews CAR-T cell advancements in lymphoma treatment, addressing T cell exhaustion and tumor immune evasion with ...

Researchers at the University of California Davis Comprehensive Cancer Center have uncovered an evolutionary change that may ...

A series of new peptides (8−25) containing different unnatural amino acids of the adamantane type (1−6), was synthesized. Possible cytotoxic activity on human cervical adenocarcinoma (HeLa), larynx ...

HR-positive/HER2-negative is the most common subtype of breast cancer in women. HR-positive/HER2-negative metastatic breast ...

In 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths worldwide, according to the World ...

DelveInsight’s Metastatic Prostate Cancer Pipeline report depicts a robust space with 80+ active players working to develop ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

Ferroptosis—a type of programmed cell death —occurs when the accumulation of iron triggers excessive oxidation of fats in cell membranes, ultimately causing the cell to break down. Cancer ...